Association of biomarker S100B and cerebral oximetry with neurological changes during carotid endarterectomy performed in awake patients
Abstract
Summary.Background: This study attempted to correlate neurological symptoms in awake patients undergoing carotid endarterectomy (CEA) under local anaesthesia (LA) with serum concentration of S100B protein and measurement of cerebral oximetry with near-infrared spectroscopy (NIRS). Patients and methods: A total of 64 consecutive CEAs in 60 patients operated under LA during an 18-month period were prospectively evaluated. A cerebral oximeter was used to measure cerebral oxygen saturation (rSO2) before and after cross-clamping along with serum concentration of the S100B protein. Selective shunting was performed when neurological changes occurred, regardless of NIRS. Neurological deterioration occurred (neurological symptoms group) in 7 (10.9 %) operations. In 57 (89.1 %) operations, the patients were neurologically stable (no neurological symptoms group). Results: The neurological symptoms that occurred after clamping correlated with an increase in the serum level of S100B (P = .040). The cut-off of 22.5 % of S100B increase was determined to be optimal for identifying patients with neurological symptoms. There was no correlation between rSO2 decline and neurological symptoms (P = .675). Two (3.1 %) perioperative strokes occurred. Conclusions: We found a correlation between neurological symptoms and serum S100B protein increase. However, because of the long evaluation time of serum S100B, this monitoring technique cannot be performed during CEA.
References
1 . The influence of contralateral carotid stenosis and occlusion on cerebral oxygen saturation during carotid artery surgery. Eur J Vasc Endovasc Surg. 1995;10(2):198–206.
2 Selective shunting with EEG monitoring is safer than routine shunting for carotid endarterectomy. Cardiovasc Surg. 1997;5(5):481–5.
3 . Comparison of near-infrared spectroscopy and somatosensory evoked potentials for the detection of cerebral ischemia during carotid endarterectomy. Stroke. 1998;29(10):2032–7.
4 . S-100B release during carotid endarterectomy under local anesthesia. Ann Vasc Surg. 2007;21(5):571–5.
5 . Proenkefalin A and protachykinin in ischemic neurological complications after cardiac surgery. Med Glas (Zenica). 2016;13(1):8–13.
6 Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem. 2006;13:3719–31.
7 . S100B concentrations increase perioperatively in jugular vein blood despite limited metabolic and inflammatory response to clinically uneventful carotid endarterectomy. Clin Chem Lab Med. 2015;53:111e7.
8 . Silent stroke and cognitive decline in asymptomatic carotid stenosis revascularization. Vascular. 2012;20:181e7.
9 . The neurological morbidity of carotid revascularisation: using markers of cellular brain injury to compare CEA and CAS. Eur J Vasc Endovasc Surg. 2007;34:552–60.
10 Fluctuations of serum neuron specific enolase and protein S-100B concentrations in relation to the use of shunt during carotid endarterectomy. PLoS One. 2015;10(4):e0124067. doi: 10.1371/journal.pone.0124067. eCollection.
11 Comparative study on carotid revascularisation (endarterectomy vs stenting) using markers of cellular brain injury, neuropsychometric tests, and diffusion-weighted magnetic resonance imaging. J Vasc Surg. 2010;51(3):584–91.
12 Failure of intraoperative jugular bulb S-100B and neuron-specific enolase sampling to predict cognitive injury after carotid endarterectomy. Neurosurgery. 2003;53(6):1243–9.
13 Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery. 2001;49(5):1076–82.
14 Using serum s100-β protein as a biomarker for comparing silent brain injury in carotid endarterectomy and carotid artery stenting. Int Angiol. 2019;38(2):136–42.
15 The role of stump pressure and cerebral oximetry in predicting ischaemic brain damage during carotid endarterectomy. Brain Inj. 2017;31(13–14):1944–50.
16 Beneficial effects of intravenous dexmedetomidine on cognitive function and cerebral injury following a carotid endarterectomy. Exp Ther Med. 2016;11(3):1128–34.
17 . Perioperative time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 & S100B protein in carotid surgery. Indian J Med Res. 2016;143(2):220–6.
18 Evaluation of subclinical cerebral injury and neuropsychologic function in patients undergoing carotid endarterectomy. Ann Vasc Surg. 2008;22(4):497–504.
19 . Correlation of cerebral oximetry with internal carotid artery stump pressures in carotid endarterectomy. Vasc Endovascular Surg. 2010;44(4):252–6.
20 . Cerebral oximetry in patients undergoing carotid endarterectomy under regional anesthesia. Stroke. 1996;27(1):49–55.
21 . Tissue oxygen index: thresholds for cerebral ischemia using near-infrared spectroscopy. Stroke. 2006;37(11):2720–5.
22 Near infrared spectroscopy monitoring during carotid endarterectomy: which threshold value is critical? Eur J Vasc Endovasc Surg. 2004;27(6):646–50.
23 Serum S-100β as a possible marker of blood-brain barrier disruption. Brain Res. 2002;940:102–4.
24 Serum neuron-specific enolase and S100 calcium binding protein B biomarker levels do not improve diagnosis of acute stroke. J R Coll Physicians Edinb. 2012;42(3):199–204.
25 . Blood biomarkers of ischaemic stroke. Neurotherapeutics. 2011;8:349–60.
26 . Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis. 2009;27:295–302.
27 . Prospective evaluation of electroencephalography, carotid artery stump pressure, and neurologic changes during 314 consecutive carotid endarterectomies performed in awake patients. J Vasc Surg. 2007;45(3):511–5.
28 . Optimal cerebral monitoring during carotid endarterectomy; neurologic response under local anesthesia. J Vasc Surg. 1985;2:775–7.
29 . Correlation of carotid artery stump pressure and neurological changes during 474 carotid endarterectomies performed in awake patients. J Vasc Surg. 2005;42:684–9.
30 . Comparison of simultaneous electroencephalographic and mental status monitoring during carotid endarterectomy with regional anesthesia. J Vasc Surg. 1998;28:1014–23.
31 A comparison of regional and general anesthesia in patients undergoing carotid endarterectomy. J Vasc Surg. 1996;24:946–56.
32 . Impairment of blood-brain barrier integrity during carotid surgery as assessed by serum S-100B protein concentrations. Clin Chem Lab Med. 2003;41:1320–2.
33 . Comparison of cerebral oximeter and evoked potential monitoring in carotid endarterectomy. Can J Anaesth. 1997;44(10):1077–81.
34 Use of transcranial cerebral oximetry to monitor regional cerebral oxygen saturation during neuroendovascular procedures. AJNR Am J Neuroradiol. 1995;16(8):1618–25.
35 . Cerebral oximetry: a useful monitor during carotid artery surgery. Anaesthesia. 1995;50(12):1041–5.
36 . Internal and external carotid contributions to near-infrared spectroscopy during carotid endarterectomy. Stroke. 1997;28(5):906–11.
37 S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychometric outcome. Ann Thorac Surg. 1999;68:2202–8.
38 Increased serum S-100B and neuron specific enolase potential markers of early nervous system involvement in essential hypertension. Clin Biochem. 2011;44:154–9.